Dermal Fillers and Botulinum Toxin Market: Hyaluronic Acid Based Dermal Fillers Projected to be the Second Most Lucrative Segment by Product Type: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027
- Healthcare, Pharmaceuticals and Medical devices
- No. of Pages: 220
- Published: 2017-08-24
- Report Code: REP-GB-4733
-
Format:
An Incisive, In-depth Analysis on the Dermal Fillers And Botulinum Toxin Market
This study offers a comprehensive, 360 degree analysis on the Dermal Fillers And Botulinum Toxin market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Dermal Fillers And Botulinum Toxin market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Celebrity endorsements and consumer market are an important growth driver
Several dermatology association members i.e. service providers and clinics have seen an increased uptake of aesthetic procedures in the year 2016. The American Academy of Facial Plastic and Reconstructive Surgery estimates that more than 80% of surgeons believed a celebrity endorsement played a vital role in the patient being willing to go under the knife and undergo treatment. The most common procedures are the application of botilinum toxin leading to wrinkle reduction by way of volume restoration. Social and mainstream media have also had an outsized impact on the customer psyche, influencing them to start these treatments early to avoid the onset of ageing or delay it as much as possible.
Rising preference for non-invasive surgical procedures across the globe
The demand for minimally invasive cosmetic treatment, a phenomenon seen worldwide, is poised to benefit the Dermal Fillers and Botulinum Toxin Market. Dermatologists prefer to treat skin diseases through less invasive procedures or topical applications in place of surgical methods. The non-surgical procedures that witnessed a dramatic spike in popularity in 2016 were dermal fillers with hyaluronic acid and botulinum toxin. Injectable treatments are chosen because of greater awareness of measurable improvement in procedures and more information dissemination.
Hyaluronic Acid and Botulinum Toxin key in dermal fillers and botulinum toxin market
Botulinum Toxin is the largest segment in the Dermal Fillers and Botulinum Toxin Market by product type and is larger than the other two segments combined. It is expected to push past US$ 5 Bn by the end of the forecast period making it imperative for key stakeholders in the Dermal Fillers and Botulinum Toxin Market to target. However, the Hyaluronic Acid segment is anticipated to witness a high CAGR of 8.5% from 2017-2027, which companies would do well to take note of while devising their Hyaluronic Acid Dermal Fillers and Botulinum Toxin Market strategies.The Botulinum Toxin segment dominated the global Dermal Fillers and Botulinum Toxin market by product type in terms of revenue in 2017, and this trend is projected to continue throughout the forecast period. Botulinum Toxin is the most attractive segment, with a market attractiveness index of 1.6 over the forecast period.
Inadequate professional training serious concern in the dermal fillers and botulinum toxin market
The treatments are sometimes administered incorrectly to patients and this can lead to serious complications with extremely adverse side-effects. Fillers are injected around the temple region of the head to even out fine lines and reduce crow’s feet. Patients could experience symptoms such as swelling, fever, and extreme pain within two days, especially if the injection punctures a facial vein during the process of administration. These unfortunate accidents would need patients to be administered a dose of antibiotics or steroids that have their own additional side-effects. At present, a limited number of medical institutions offer the required advanced training and this is a particular problem in resource-starved, poorer countries in the world where such treatments are more of a luxury only enjoyed by the privileged few.
High cost a major restraint in the dermal fillers and botulinum toxin market
The cost of botolinum toxin treatments is on the higher side and multiple sessions are necessary to achieve the desired results. The surgeon or physician cost alone is approximately half the cost in the case of dermal fillers; and fillers such as HA, PLLA, CaHA last for a maximum period of two years. Most of them are naturally occurring in the body and they get degraded quickly, which is why multiple sessions are needed, thereby driving up the cost of treatment substantially. Frequent visits to the surgeon or physician is the norm that could potentially stifle the growth prospects of the global Dermal Fillers and Botulinum Toxin Market.
Report Introduction
Customers worldwide are increasingly opting for aesthetic procedures and treatments to look younger than their age suggests. The proliferation of qualified plastic surgeons and their well-established networks play a major role in the dermal fillers and botulinum toxin market. Future Market Insights has released a new report titled ‘Dermal Fillers and Botulinum Toxin Market: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027’ that is an exhaustive analysis of the dermal fillers and botulinum toxin market on the basis of key parameters such as Y-o-Y growth, CAGR, and absolute dollar opportunity.
The global dermal fillers and botulinum toxin market has been studied on the basis of seven key geographic regions viz. North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and MEA. The dermal fillers and botulinum toxin market report devotes an equal amount of attention to both developed and emerging regions by focussing on the drivers, restraints, opportunities and threats that exist in the regional dermal fillers and botulinum toxin market. The historical market size of the largest countries in every region has been compared and contrasted with the anticipated future growth so that key stakeholders in the dermal fillers and botulinum toxin market can gain a clear understanding. The market attractiveness analysis on the basis of the taxonomy concludes this section of the dermal fillers and botulinum toxin market report.
The dermal fillers and botulinum toxin market report begins with the executive summary that is concise and comprehensive. The section includes an overview comprising macroeconomic factors, important facts, and the revenue share by both product type and application. Our experts have analysed the dermal fillers and botulinum toxin market extensively and made their recommendations that you would be highly recommended to take into consideration while devising your long-term market strategies. The recommendations take the form of an overall market approach, segment and region to target with a differentiating strategy to race past your competition in the dermal fillers and botulinum toxin market.
The dermal fillers and botulinum toxin market introduction chapter follows the executive summary and should ideally be read in tandem with it. This section gives readers a grassroots level understanding of the dermal fillers and botulinum toxin market by way of the definition as well as the taxonomy of the dermal fillers and botulinum toxin market.
Dermal Fillers and Botulinum Toxin Market: Taxonomy
|
Region |
Application |
Product Type |
|---|---|---|
|
|
|
The pressure to look younger and fitter has never been more acute than in the 21st century. Key players actively involved in the dermal fillers and botulinum toxin market are more than willing to cater to this demand and are offering a diverse suite of products and services. As a new entrant seeking to enter the dermal fillers and botulinum toxin market or an incumbent who wishes to change your go-to- market strategy, you would do well to understand what your immediate rivals are planning in the dermal fillers and botulinum toxin market. The competition dashboard features some of the companies operating in the dermal fillers and botulinum toxin market by highlighting the key financials, revenue growth, operating and net margin, key ratios, and industry classification codes. A SWOT analysis, recent developments and a broad company strategy outline are highlighted in this section.
Research Methodology
The research methodology adopted by Future Market Insights is considered to be a benchmark in the industry. Our team of diverse and knowledgeable experts have years of experience and they put this to good use during their primary and secondary research in the dermal fillers and botulinum toxin market. They prepare a questionnaire that enables them to gather all the relevant information pertaining to the dermal fillers and botulinum toxin market. The facts are thoroughly scrutinised with the help of the triangulation method and the report data is finally validated using advanced company tools to deliver the required insights pertaining to the dermal fillers and botulinum toxin market.
Dermal Fillers And Botulinum Toxin Market Reports - Table of Contents
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
18. Assumptions and Acronyms Used
19. Research Methodology
Dermal Fillers And Botulinum Toxin Market Reports - List of Tables
Table 01: Global Dermal Fillers and Botulinum Toxin Market – Global FDA Dermal Fillers
Table 02: North America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 03: North America Dermal Fillers Market Volume (1 ml vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 04: North America Botulinum Toxin Market Volume (100 unit vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 05: North America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application
Table 06: North America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 07: North America Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)
Table 08: Latin America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 09: Latin America Dermal Fillers Market Volume (1 ml vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 10: Latin America Botulinum Toxin Market Volume (100 unit vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 11: Latin America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application
Table 12: Latin America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 13: Latin America Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)
Table 14: Western Europe Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 15: Western Europe Dermal Fillers Market Volume (1 ml vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 16: Western Europe Botulinum Toxin Market Volume (100 unit vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 17: Western Europe Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application
Table 18: Western Europe Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 19: Western Europe Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)
Table 20: Eastern Europe Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 21: Eastern Europe Dermal Fillers Market Volume (1 ml vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 22: Eastern Europe Botulinum Toxin Market Volume (100 unit vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 23: Eastern Europe Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application
Table 24: Eastern Europe Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 25: Eastern Europe Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)
Table 26: APEJ Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 27: APEJ Dermal Fillers Market Volume (1 ml vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 28: APEJ Botulinum Toxin Market Volume (100 unit vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 29: APEJ Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application
Table 30: APEJ Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 31: APEJ Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)
Table 32: Japan Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 33: Japan Dermal Fillers Market Volume (1 ml vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 34: Japan Botulinum Toxin Market Volume (100 unit vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 35: Japan Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application
Table 36: Japan Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 37: Japan Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)
Table 38: MEA Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 39: MEA Dermal Fillers Market Volume (1 ml vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 40: MEA Botulinum Toxin Market Volume (100 unit vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 41: MEA Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application
Table 42: MEA Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 43: MEA Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)
Table 44 Global Dermal Fillers and Botulinum Toxin Market: Intensity Mapping by Company
Table 45 Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 46 Global Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 47 Global Dermal Fillers Market Volume (1 ml vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 48 Global Botulinum Toxin Market Volume (100 unit vial) Analysis 2012–2016 and Forecast 2017–2027, By Product Type
Table 49 Global Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application
Dermal Fillers And Botulinum Toxin Market Reports - List of Figures
Figure 01: U.S FDA Regulatory Approval for Medical Devices
Figure 02: Europe Regulatory Approval for Medical Devices
Figure 03: U.S. FDA approved Dermal Fillers
Figure 04: North America Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027
Figure 06: North America Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)
Figure 05: North America Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)
Figure 07: North America Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)
Figure 08: North America Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 09: North America Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 10: U.S. Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 11: U.S. Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 12: Canada Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 13: Canada Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 14: North America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027
Figure 15: North America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027
Figure 16: North America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Country, 2017-2027
Figure 17: North America - Drivers & Restrains Impact Analysis
Figure 18: Latin America Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027
Figure 19: Latin America Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)
Figure 20: Latin America Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)
Figure 21: Latin America Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)
Figure 22: Latin America Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 23: Latin America Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 24: Brazil Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 25: Brazil Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 26: Mexico Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 27: Mexico Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 28: Argentina Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 29: Argentina Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 30: Rest of Latin America Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 31: Rest of Latin America Dermal Fillers and Botulinum Toxin Market Forecast, 2012 - 2016
Figure 32: Latin America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027
Figure 33: Latin America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027
Figure 34: Latin America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Country, 2017-2027
Figure 35: Latin America - Drivers & Restraint Impact Analysis
Figure 36: Western Europe Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027
Figure 37: Western Europe Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)
Figure 38: Western Europe Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)
Figure 39: Western Europe Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)
Figure 40: Western Europe Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 41: Western Europe Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 42: U.K. Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 43: U.K. Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 44: Germany Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 45: Germany Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 46: France Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 47: France Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 48: Italy Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 49: Italy Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 50: Spain Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 51: Spain Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 52: Nordics Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 53: Nordics Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 54: Benelux Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 55: Benelux Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 56: Rest of Western Europe Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 57: Rest of Western Europe Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 58: Western Europe Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027
Figure 59: Western Europe Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027
Figure 60: Western Europe Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027
Figure 61: Western Europe - Drivers & Restraint Impact Analysis
Figure 62: Eastern Europe Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027
Figure 63: Eastern Europe Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)
Figure 64: Eastern Europe Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)
Figure 65: Eastern Europe Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)
Figure 66: Eastern Europe Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 67: Eastern Europe Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 68: Russia Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 69: Russia Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 70: Poland Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 71: Poland Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 72: Rest of Eastern Europe Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 73: Rest of Eastern Europe Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 74: Eastern Europe Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027
Figure 75: Eastern Europe Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027
Figure 76: Eastern Europe Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027
Figure 77: Eastern Europe - Drivers & Restraint Impact Analysis
Figure 78: APEJ Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027
Figure 79: APEJ Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)
Figure 80: APEJ Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)
Figure 81: APEJ Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)
Figure 82: APEJ Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 83: APEJ Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 84: China Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 85: China Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 86: India Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 87: India Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 88: Australia and NZ Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 89: Australia and NZ Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 90: ASEAN Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 91: ASEAN Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 92: Rest of APEJ Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 93: Rest of APEJ Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 94: APEJ Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027
Figure 95: APEJ Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027
Figure 96: APEJ Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027
Figure 97: APEJ - Drivers & Restraint Impact Analysis
Figure 98: Japan Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027
Figure 99: Figure Japan Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)
Figure 100: Japan Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)
Figure 101: Japan Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 102: Japan Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 103: Japan Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027
Figure 104: Japan Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027
Figure 105: Japan- Drivers & Restraint Impact Analysis
Figure 106: MEA Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027
Figure 108: MEA Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)
Figure 107: MEA Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)
Figure 109: MEA Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)
Figure 110: MEA Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 111: MEA Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 112: South Africa Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 113: South Africa Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 114: GCC Countries Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 115: GCC Countries Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 116: Rest of MEA Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 117: Rest of MEA Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 118: MEA Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027
Figure 119: MEA Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027
Figure 120: MEA Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027
Figure 121: MEA Drivers & Restraint Impact Analysis
Figure 122 : Dermal Fillers and Botulinum Toxin Market Forecast Factors – Relevance and Impact
Figure 123: Global Dermal Fillers and Botulinum Toxin Market Share Analysis
Figure 124: Global Dermal Fillers Market Share Analysis
Figure 125: Global Botulinum Toxin Market Share Analysis
Figure 126: Global Bone Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) By Region, 2017 & 2027
Figure 127: Global Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Region, 2017-2027
Figure 128: Global Bone Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) By Product Type, 2017 & 2027
Figure 129: Global Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027
Figure 130: Global Bone Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) By Application, 2017 & 2027
Figure 131: Global Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027
Figure 132: Global Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016
Figure 133: Global Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027
Figure 134: Global Dermal Fillers and Botulinum Toxin Market Absolute $ Opportunity, 2012 - 2016
Figure 135: Global Dermal Fillers and Botulinum Toxin Market Absolute $ Opportunity, 2017 - 2027
Figure 136: Global Dermal Fillers and Botulinum Toxin Market - Value Chain
Get in touch
Harish Tiwari
Global Head - Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.